SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

by Staffurth John N, Gollins Simon, Al-Mokhtar Ruby, Griffiths Gareth O, Nixon Lisette S, Hurt Christopher N, Phillips Ceri J, Blazeby Jane M, Crosby Tom D
Published 2011-10-01